Repositioning candidate gene approaches in the post-GWAS era: a clinical perspective from psychiatric pharmacogenetics. [PDF]
Pjevac M, Bon J, Dolžan V.
europepmc +1 more source
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: updated analysis of survival and circulating and genetic biomarkers from the phase II nITRO trial. [PDF]
Scarlato E +12 more
europepmc +1 more source
Pharmacogenomics Global Research Network (PGRN) 2026 Scientific Meeting in Collaboration with ClinPGx. [PDF]
europepmc +1 more source
A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report. [PDF]
Mazhindu TA +7 more
europepmc +1 more source
Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe. [PDF]
Mazhindu TA +5 more
europepmc +1 more source
Advancing Precision Dosing of 5-FU: Population PK Model Development, Limited Sampling Strategies, and Fit-for-Use Application. [PDF]
Tan Z +10 more
europepmc +1 more source
Clinically Relevant Pharmacogenomic Variant Frequencies in Kazakh, Russian, and Uzbek Population Groups Residing in Kazakhstan. [PDF]
Zhaniyazov Z +11 more
europepmc +1 more source
Clinically actionable pharmacogenomic variants for anticancer therapy in Nigeria: first comprehensive variant profiling in underrepresented Nigerian cohorts. [PDF]
Ukpe MP, Ezeanuka AC.
europepmc +1 more source
Genomic and epigenomic diversity of breast cancer across Western and MENA populations: implications for precision oncology. [PDF]
Shaikh S +11 more
europepmc +1 more source

